193 related articles for article (PubMed ID: 29274237)
1. Lipase-catalyzed kinetic resolution of novel antitubercular benzoxazole derivatives.
Łukowska-Chojnacka E; Kowalkowska A; Napiórkowska A
Chirality; 2018 Apr; 30(4):457-468. PubMed ID: 29274237
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
Nikonenko BV; Kornienko A; Majorov K; Ivanov P; Kondratieva T; Korotetskaya M; Apt AS; Salina E; Velezheva V
Antimicrob Agents Chemother; 2016 Oct; 60(10):6422-4. PubMed ID: 27503657
[TBL] [Abstract][Full Text] [Related]
4. Lipase-Catalyzed Kinetic Resolution of Novel Antifungal N-Substituted Benzimidazole Derivatives.
Łukowska-Chojnacka E; Staniszewska M; Bondaryk M; Maurin JK; Bretner M
Chirality; 2016 Apr; 28(4):347-54. PubMed ID: 26922853
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic hydrolysis of esters containing a tetrazole ring.
Łukowska-Chojnacka E; Mierzejewska J
Chirality; 2014 Dec; 26(12):811-6. PubMed ID: 25065812
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
8. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.
Castagnolo D; Radi M; Dessì F; Manetti F; Saddi M; Meleddu R; De Logu A; Botta M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2203-5. PubMed ID: 19299129
[TBL] [Abstract][Full Text] [Related]
12. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitubercular screening of [(2-chloroquinolin-3-yl)methyl] thiocarbamide derivatives.
Kumar S; Upmanyu N; Afzal O; Bawa S
Chem Biol Drug Des; 2014 Nov; 84(5):522-30. PubMed ID: 24750991
[TBL] [Abstract][Full Text] [Related]
14. Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis.
Ashtekar DR; Costa-Periera R; Shrinivasan T; Iyyer R; Vishvanathan N; Rittel W
Diagn Microbiol Infect Dis; 1991; 14(6):465-71. PubMed ID: 1802533
[TBL] [Abstract][Full Text] [Related]
15. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
16. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides.
Servusova-Vanaskova B; Paterova P; Garaj V; Mandikova J; Kunes J; Naesens L; Jílek P; Dolezal M; Zitko J
Chem Biol Drug Des; 2015 Oct; 86(4):674-81. PubMed ID: 25676890
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
19. Quinazoline derivatives with antitubercular activity.
Kunes J; Bazant J; Pour M; Waisser K; Slosárek M; Janota J
Farmaco; 2000; 55(11-12):725-9. PubMed ID: 11204949
[TBL] [Abstract][Full Text] [Related]
20. In-vitro antimycobacterial activity of new synthetic amidrazone derivatives.
Banfi E; Mamolo MG; Vio L; Predominato M
J Chemother; 1993 Jun; 5(3):164-7. PubMed ID: 8371125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]